Orgenesis gets Nasdaq delisting notice; director resigns

Orgenesis Inc.

Mark Goodman resigned as director effective Oct 19, 2024, for personal reasons; no disagreement with company.
Goodman will continue as strategic advisor to Orgenesis.
Nasdaq notified Orgenesis on Oct 17 it plans to file Form 25 to delist common stock from Nasdaq.
Delisting effective 10 days after Form 25 filing; stock began trading on OTCQX on Oct 21.
Stock will remain registered under Section 12(g) of Exchange Act after deregistration under 12(b).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Goodman

director

Orgenesis Inc.

Effective: 2024-10-19
Filed: October 23, 2024, 7:59 PM ET

On October 19, 2024, Mark Goodman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Goodman resigned as director at Orgenesis Inc..

Action: resigned
Role: director

Exact text from the filing

On October 19, 2024, Mark Goodman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-042252

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.